Lucid Diagnostics (LUCD) Revenue Growth (1y) (2022 - 2026)
Lucid Diagnostics (LUCD) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 6.08% |
| 10 | Lucid Diagnostics | 129.42 Mn | 101.55 Mn | -325,000.00 | 57.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.00% |
| Dec 31, 2025 | 25.15% |
| Sep 30, 2025 | 3.33% |
| Jun 30, 2025 | 22.95% |
| Mar 31, 2025 | -17.28% |
| Dec 31, 2024 | 15.10% |
| Sep 30, 2024 | 49.68% |
| Jun 30, 2024 | 513.84% |
| Mar 31, 2024 | 124.44% |
| Dec 31, 2023 | 828.57% |
| Sep 30, 2023 | 930.26% |
| Mar 31, 2023 | 135.98% |
| Dec 31, 2022 | -62.67% |
| Sep 30, 2022 | -62.00% |